Jin-Ming Liu
Tongji University
34 Papers
27 Citations
Jin-Ming Liu is an academic researcher from Tongji University. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 10, co-authored 18 publications.
Chat about Author
Papers
Selexipag for the treatment of pulmonary arterial hypertension.
Olivier Sitbon,Richard N. Channick,Kelly Chin,Aline Frey,Sean Gaine,Nazzareno Galiè,Hossein Ardeschir Ghofrani,Marius M. Hoeper,Irene M. Lang,R Preiss,Lewis J. Rubin,Lilla Di Scala,Victor F. Tapson,Igor Adzerikho,Jin-Ming Liu,Olga Moiseeva,Xiaofeng Zeng,Gérald Simonneau,Vallerie V. McLaughlin +18 more
TL;DR: The risk of the primary composite end point of death or a complication related to pulmonary arterial hypertension was significantly lower with selexipag than with placebo and there was no significant difference in mortality between the two study groups.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Hossein Ardeschir Ghofrani,Hossein Ardeschir Ghofrani,Gérald Simonneau,Gérald Simonneau,Andrea Maria D'Armini,Peter F. Fedullo,Luke Howard,Luke Howard,Xavier Jaïs,Xavier Jaïs,David P. Jenkins,Zhi-Cheng Jing,Michael M. Madani,Nicolas Martin,Eckhard Mayer,Kelly Papadakis,Dominik Richard,Nick H. Kim,Irene Lang,Christian M. Kähler,Marion Delcroix,Zoheir Bshouty,Pablo Sepulveda Varela,Yuanhua Yang,Jin-Ming Liu,Gang-Cheng Zhang,Nuofu Zhang,Yuhong Mi,Xian-Yang Zhu,Pavel Jansa,Grégoire Prévot,Hélène Bouvaist,Olivier Sanchez,Friedrich Grimminger,Matthias Held,Heinrike Wilkens,Stephan Rosenkranz,Ekkehard Grünig,Kristóf Karlócai,András Temesvári,Istvan Edes,Sigita Aidietienė,Skaidrius Miliauskas,Tomas Rene Pulido Zamudio,Carlos Jerjes Sanchez,Anton Vonk Noordegraaf,Jerzy Lewczuk,Piotr Podolec,Jarosław Kasprzak,Tatiana Mularek-Kubzdela,Ryszard Grzywna,Keertan Dheda,Olga Moiseeva,Alexander Chernyavskiy,Vladimir M. Shipulin,Olga Barbarash,Tamila Vitalievna Martynyuk,Hyung Kwan Kim,Jun Bean Park,Jae Seung Lee,Rudolf Speich,Silvia Ulrich,John-David Aubert,Arintaya Phrommintikul,Nattapong Jaimchariyatam,Suree Sompradeekul,Zeynep Pinar Onen,Gulfer Okumus,Lyubomyr Solovey,Volodymyr Gavrysyuk,Luke S. Howard,Joanna Pepke-Zaba,Robin Condliffe,John McConnell,Kim M. Kerr,Lan Hieu Nguyen,Nguyen Vinh Pham +76 more
TL;DR: In MERIT-1, macitentan significantly improved PVR in patients with inoperable CTEPH and was well tolerated, and resting PVR at week 16, expressed as percentage of PVR measured at baseline.
262
Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
Lan Wang,Yuan-Zhe Jin,Qin-Hua Zhao,Rong Jiang,Wen-Hui Wu,Su-Gang Gong,Jing He,Jin-Ming Liu,Zhi-Cheng Jing,Zhi-Cheng Jing +9 more
TL;DR: It is suggested that the short-term use of iloprost in patients with COPD-PH is effective and well tolerated, and there were no significant differences in arterial blood gas and Qs/Qt between patients with nonsevere and severe forms of COPD
Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension.
Rui Zhang,Xiao-Jian Wang,Hong-Da Zhang,Xiao-Qing Sun,Qin-Hua Zhao,Lan Wang,Jing He,Xin Jiang,Jin-Ming Liu,Zhi-Cheng Jing +9 more
TL;DR: Plasma NOx was significantly lower, and related to haemodynamics, mortality and BMPR2 mutation in patients with IPAH, suggesting that reduced NO synthesis contributes to the pathogenesis of IPAH.
28
Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension
Qin-Hua Zhao,Lan Wang,Bigyan Pudasaini,Rong Jiang,Ping Yuan,Su-Gang Gong,Jian Guo,Qiang Xiao,Hui Liu,Cheng Wu,Zhi-Cheng Jing,Jin-Ming Liu +11 more
TL;DR: Doppler echocardiography is usually the first diagnostic investigation for patients suspected with pulmonary hypertension (PH), but it is often inaccurate when used alone, especially in mild PH.
25